NIH Panel Counters FDA: No Solid Data on Plasma for COVID-19

September 3, 2020

(Medscape) – Current data are insufficient to recommend either for or against using convalescent plasma to treat patients who have COVID-19, the National Institutes of Health’s (NIH) COVID-19 Treatment Guidelines Panel said Tuesday. “Convalescent plasma should not be considered standard of care for the treatment of patients with COVID-19,” the committee said.